FDA’s December 2025 OPOE list features 784 prescription drugs, 73 OTC drugs

Data Compilation
#PharmaFlow

Pipeline Prospector 2025 highlights: FDA approves pill version of Novo’s Wegovy; BioMarin acquires Amicus for US$ 4.8 bn

Stock Recap
#PipelineProspector

Adenosine

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

31 API Suppliers, 20 USDMF, 5 CEP/COS, 2 EU WC, 4 NDC API, 12 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

5 Drugs in Development

5 Drugs in Development

FINISHED DOSAGE FORMULATIONS

84 FDF Dossiers, 33 FDA Orange Book, 29 Europe, 4 Canada, 2 South Africa, 16 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 3MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;INTRAVENOUS - 60MG/20ML (3MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;INTRAVENOUS - 90MG/30ML (3MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 11 Evonik, 6 Rochem International Inc, 14 SPI Pharma, 1 Pharm-RX Chemical, 3 Gangwal Healthcare, 2 Kewpie Corporation, 24 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 3 Pfanstiehl, 1 Capital Farma, 35 Kirsch Pharma, 4 ACG Worldwide, 11 Actylis, 2 Aeon Procare, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 20 BASF, 1 Bioplus Life Sciences, 2 BioSpectra, 5 CD Formulation, 2 Clariant, 16 Corel Pharma Chem, 22 DKSH, 2 Esteem Industries, 4 Finar, 16 Gangwal Chemicals, 2 Hayashibara, 3 Ideal Cures, 2 Ingredion Pharma Solutions, 9 Kerry, 1 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 6 Lubrizol Life Science Health, 12 Microlex e.U, 4 Nanjing Bold Chemical, 2 Nippon Fine Chemical, 1 Novo Excipients, 4 Pluviaendo, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 31 Roquette, 28 Seppic, 3 Shandong Focus Biotechnology Co., Ltd, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 3 Sigachi Industries, 1 Symrise, 3 The Dow Chemical Company, 1 TopChem Pharmaceuticals, 2 Valens Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

87 Topical, 69 Solubilizers, 65 Thickeners and Stabilizers, 64 Parenteral, 46 Emulsifying Agents, 45 Coating Systems & Additives, 37 Fillers, Diluents & Binders, 26 Surfactant & Foaming Agents, 26 Taste Masking, 25 Film Formers & Plasticizers, 17 Rheology Modifiers, 16 Controlled & Modified Release, 14 Direct Compression, 12 Lubricants & Glidants, 11 Co-Processed Excipients, 11 API Stability Enhancers, 10 Granulation, 10 Chewable & Orodispersible Aids, 9 Empty Capsules, 7 Disintegrants & Superdisintegrants, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

18 News #PharmaBuzz

18 News #PharmaBuzz

GLOBAL SALES INFORMATION

3 Annual Reports

3 Annual Reports

MARKET PLACE

22 APIs, 1 FDF Dossiers

REF. STANDARDS & IMPURITIES

1 EDQM, 5 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
29/01/2026	Actylis	U.S.A	PHARMA WALDHOF GMBH Duesseldorf DE	CEP 2025-070 - Rev 00	Adenosine	2025-11-26	Valid	Chemical		1486
29/01/2026	Diagnostic Chemicals Limited CA C1E 2A6 Charlottetown	Mexico	Diagnostic Chemicals Limited Charlottetown CA	R0-CEP 2001-156 - Rev 03	Adenosine Deaminase	2005-06-30	Expired	TSE	2007-04-29

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Adenosine

Adenosine

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

31 API Suppliers

20 USDMF

5 CEP/COS

2 EU WC

4 NDC API

12 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

5 Drugs in Development

FINISHED DOSAGE FORMULATIONS

84 FDF Dossiers

33 FDA Orange Book

29 Europe

4 Canada

2 South Africa

16 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 3MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;INTRAVENOUS - 60MG/20ML (3MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;INTRAVENOUS - 90MG/30ML (3MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI

11 Evonik

6 Rochem International Inc

14 SPI Pharma

1 Pharm-RX Chemical

3 Gangwal Healthcare

2 Kewpie Corporation

24 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

3 Pfanstiehl

1 Capital Farma

35 Kirsch Pharma

4 ACG Worldwide

11 Actylis

2 Aeon Procare

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

20 BASF

1 Bioplus Life Sciences

2 BioSpectra

5 CD Formulation

2 Clariant

16 Corel Pharma Chem

22 DKSH

2 Esteem Industries

4 Finar

16 Gangwal Chemicals

2 Hayashibara

3 Ideal Cures

2 Ingredion Pharma Solutions

9 Kerry

1 Keval Exports

4 Kima Chemical

6 Lonza Capsugel

6 Lubrizol Life Science Health

12 Microlex e.U

4 Nanjing Bold Chemical

2 Nippon Fine Chemical

1 Novo Excipients

4 Pluviaendo

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

31 Roquette

28 Seppic

3 Shandong Focus Biotechnology Co., Ltd

2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

3 Sigachi Industries

1 Symrise

3 The Dow Chemical Company

1 TopChem Pharmaceuticals

2 Valens Pharmachem

1 Vertellus

INJECTABLE;INJECTION - 3MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION;INTRAVENOUS - 60MG/20ML (3MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION;INTRAVENOUS - 90MG/30ML (3MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons